Unité Mixte de Recherche CNRS 7276 - INSERM U1262 - Université de Limoges, CBRS, 2 rue du Dr Marcland, 87025 Limoges, France; Silab R&D Department, Brive, France.
Silab R&D Department, Brive, France.
Drug Discov Today. 2021 Jan;26(1):248-255. doi: 10.1016/j.drudis.2020.10.023. Epub 2020 Nov 1.
Skin is a vital protective organ, the main role of which is to provide a physical barrier and to prevent the entry of pathogens. Various pathologies, such as atopic dermatitis (AD), psoriasis (PSO), or skin cancers, can affect the skin, and all show a high and increasing prevalence. Many antibodies are currently used in the treatment of these diseases. However, various studies are underway for the development of new biologics directed against specific targets. In this review, we describe current biologics used in skin pathologies as well as antibodies in development. We also discuss various immunotherapy examples that use new delivery technologies, such as microneedle patch, nanoparticles (NPs), liposomes, or gel formulation.
皮肤是一种至关重要的保护器官,其主要作用是提供物理屏障,防止病原体进入。各种疾病,如特应性皮炎(AD)、银屑病(PSO)或皮肤癌,都可能影响皮肤,且所有这些疾病的患病率都很高且呈上升趋势。目前有许多抗体可用于这些疾病的治疗。然而,目前正在进行各种针对特定靶点的新型生物制剂的开发研究。在这篇综述中,我们描述了目前用于皮肤疾病的生物制剂以及正在开发中的抗体。我们还讨论了各种免疫疗法的例子,这些疗法使用了新的递药技术,如微针贴片、纳米颗粒(NPs)、脂质体或凝胶制剂。